Delivery Order SPE2DB25D3012-SPE2DB25FWYEH
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Botox 100 Unit Vials with a ceiling value of $10,336.32. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract utilizes no set-aside designation, reflecting open competition among eligible vendors. This delivery...
- The Defense Logistics Agency awarded a $30,112.50 delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of 200-unit vials of BOTOX under a firm fixed-price contract. The order is due for completion by July 31, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This is a non-set-aside competitive award, reflecting AmerisourceBergen's established capability to meet federal pharmaceutical procurement requirements through open...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Botox 100-unit vials, with a ceiling value of $2,153.40 and an ultimate completion date of June 24, 2025. This non-competitive delivery order carries firm fixed pricing and represents a competitive award under an existing contract vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 26, 2025, for the supply of BOTOX 100 Unit Vials with a ceiling value of $43,068.00. This firm fixed-price delivery order, with an ultimate completion date of July 18, 2025, represents a competitive award with no set-aside designation. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, leveraging the company's extensive pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of BOTOX 100 unit vials with a ceiling value of $1,722.72. This firm fixed price delivery order represents a non-set-aside competitive award with an ultimate completion date of August 25, 2025. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $42,739.50 to AmerisourceBergen Drug Corp for supply of Botox 200 unit vials, with a completion date of August 20, 2025. This competitive award, issued on July 30, 2025, carries no set-aside designation and employs firm fixed pricing terms. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for 200-unit vials of BOTOX with a ceiling value of $4,273.95. This competitively awarded, firm fixed-price delivery order represents part of AmerisourceBergen's broader pharmaceutical supply relationship with the federal government and is scheduled for completion by June 23, 2025. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania facility, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $30,772.44 to AmerisourceBergen Drug Corp for the supply of Botox 200 Unit Vials. This competitively awarded, firm fixed-price contract has an ultimate completion date of July 21, 2025, and involves no set-aside designation. The award was made on June 27, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Botox 200 Unit Vials with a ceiling value of $41,029.92. This firm fixed-price delivery order is expected to be completed by June 24, 2025, and will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location. The award utilized no set-aside designation, indicating competitive procurement against qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a $15,056.25 delivery order to AmerisourceBergen Drug Corp for 200-unit vials of Botox on August 4, 2025, with an ultimate completion date of August 25, 2025. This competitive award utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken,...
- SPE2DB25D3012Indefinite Delivery Contract
- SPE2DB25D3012-SPE2DB25FWYEHDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Botox 200 Unit Vials with a ceiling value of $25,643.70 and firm fixed pricing. This is a non-set-aside, competitively awarded contract with an ultimate completion date of July 17, 2025, and performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor vehicle valued through December 2026 that supplies a comprehensive range of medications and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains an extensive portfolio of federal contract awards with the DLA Medical Supply Chain, encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. This particular delivery order represents a routine fulfillment transaction within the company's established federal contracting relationship, leveraging its capacity to meet military healthcare procurement requirements through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 6/25/25 |